The Drug Regulation and Reform Act of 1978 permits what?

• A. Briefer investigation of new drugs, allowing earlier access
• B. Longer clinical trials
• C. Only hospital use
• D. No recalls allowed

Answer: (A)

This item tests how the Drug Regulation and Reform Act of 1978 impacted drug approval by allowing a shorter pre-market investigation, which lets patients gain earlier access to new medicines. The idea is to speed up the review process for drugs, especially when they may benefit patients with serious or life‑threatening conditions, while still keeping safety checks through post‑marketing monitoring and required follow-up studies. In practice, this means a drug can reach the market sooner than with longer, more traditional trials, rather than delaying access. It’s not about restricting use to hospitals or eliminating recalls; recalls are part of post‑approval safety, and the act’s aim was to shorten the time to availability with continued safety oversight.